NCI Expert Stresses Importance of Multimodal Imaging in Prostate Cancer

September 6, 2018 – Multimodality imaging holds the keys to providing personalized therapy to patients with prostate cancer, said Peter L. Choyke, MD, FACP. Each screening platform has pros and cons, but their limitations can be erased with a combined effort, added Choyke, who is director of the Molecular Imaging Program and head of the Imaging Section at the National Cancer Institute (NCI). For example, an MRI gives a standard anatomical overview of a tumor but … (leggi tutto)